SONASID S.A. (CBSE:SID)

Lumos Pharma Ratios and Metrics

Market cap in millions MAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 11, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	9,575	3,837	2,574	2,028	2,399	1,170
Market Cap Growth	75.70%	49.08%	26.92%	-15.45%	105.00%	20.00%
Enterprise Value	8,951	3,171	1,902	1,162	1,608	549
Last Close Price	2455.00	967.91	634.18	474.63	532.90	256.93
PE Ratio	67.80	27.17	39.55	23.60	22.26	-
Forward PE	90.26	46.41	28.08	14.61	25.91	-
PS Ratio	1.74	0.70	0.52	0.42	0.53	0.37
PB Ratio	5.09	2.04	1.42	1.10	1.27	0.65
P/TBV Ratio	5.11	2.05	1.42	1.10	1.27	0.65
P/FCF Ratio	150.85	60.46	38.24	52.46	15.51	4.75
P/OCF Ratio	36.21	14.51	8.49	10.90	9.55	3.05
EV/Sales Ratio	1.63	0.58	0.38	0.24	0.36	0.17
EV/EBITDA Ratio	24.43	9.04	7.91	3.71	5.30	4.73
EV/EBIT Ratio	40.26	14.27	16.26	7.14	9.65	-
EV/FCF Ratio	141.03	49.97	28.25	30.06	10.40	2.23
Debt / Equity Ratio	0.05	0.05	0.06	0.06	0.06	0.07
Debt / EBITDA Ratio	0.27	0.27	0.42	0.33	0.37	0.96
Debt / FCF Ratio	1.58	1.58	1.63	2.82	0.75	0.50
Asset Turnover	1.08	1.08	1.06	1.15	1.17	0.86
Inventory Turnover	4.43	4.43	4.11	5.19	6.28	5.31
Quick Ratio	0.90	0.90	0.91	0.95	1.21	1.21
Current Ratio	1.25	1.25	1.29	1.41	1.65	1.60
Return on Equity (ROE)	7.67%	7.67%	3.56%	4.61%	5.83%	-1.52%
Return on Assets (ROA)	2.73%	2.73%	1.54%	2.40%	2.72%	-0.37%
Return on Capital (ROIC)	7.12%	7.12%	3.77%	5.14%	5.29%	-0.71%
Return on Capital Employed (ROCE)	9.50%	9.50%	5.00%	6.80%	6.80%	-
Earnings Yield	1.48%	3.68%	2.53%	4.24%	4.49%	-2.40%
FCF Yield	0.66%	1.65%	2.61%	1.91%	6.45%	21.04%
Dividend Yield	1.59%	4.03%	3.31%	6.32%	7.13%	2.72%
Payout Ratio	57.99%	57.99%	179.79%	172.47%	25.30%	-
Total Shareholder Return	1.60%	4.03%	3.31%	6.32%	7.13%	2.72%

Updated May 2, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.